Open access

Golimumab administered subcutaneously every 4 weeks in ankylosing spondylitis: 104-week results of the GO-RAISE study
Jürgen Braun, Atul Deodhar, Robert D Inman, Désirée van der Heijde, Michael Mack, Stephen Xu, Benjamin Hsu

Annals of the Rheumatic Diseases May 2012, 71 (5) 661-667; DOI: 10.1136/ard.2011.154799
Efficacy of tocilizumab in patients with moderate to severe active rheumatoid arthritis and a previous inadequate response to disease-modifying antirheumatic drugs: the ROSE study
Yusuf Yazici, Jeffrey R Curtis, Akgun Ince, Herbert Baraf, Raymond L Malamet, Lichen L Teng, Arthur Kavanaugh

Annals of the Rheumatic Diseases Feb 2012, 71 (2) 198-205; DOI: 10.1136/ard.2010.148700
Exploratory analyses of the association of MRI with clinical, laboratory and radiographic findings in patients with rheumatoid arthritis
Paul Emery, Désirée van der Heijde, Mikkel Østergaard, Philip G Conaghan, Mark C Genovese, Edward C Keystone, Roy Fleischmann, Elizabeth C Hsia, Weichun Xu, Stephen Xu, Mahboob U Rahman

Annals of the Rheumatic Diseases Dec 2011, 70 (12) 2126-2130; DOI: 10.1136/ard.2011.154500
Clinical response and tolerability to abatacept in patients with rheumatoid arthritis previously treated with infliximab or abatacept: open-label extension of the ATTEST Study
Michael Schiff, Mauro Keiserman, Christine Codding, Suthin Songcharoen, Alberto Berman, Sauithree Nayiager, Cristina Saldate, Richard Aranda, Jean-Claude Becker, Marleen Nys, Manuela le Bars, Diane Moniz Reed, Coralie Poncet, Maxime Dougados

Annals of the Rheumatic Diseases Nov 2011, 70 (11) 2003-2007; DOI: 10.1136/annrheumdis-2011-200316
Mavrilimumab, a human monoclonal antibody targeting GM-CSF receptor-α, in subjects with rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase I, first-in-human study
Gerd R Burmester, Eugen Feist, Matthew A Sleeman, Bing Wang, Barbara White, Fabio Magrini

Annals of the Rheumatic Diseases Sep 2011, 70 (9) 1542-1549; DOI: 10.1136/ard.2010.146225
Continued inhibition of structural damage over 2 years in patients with rheumatoid arthritis treated with rituximab in combination with methotrexate
Stanley B Cohen, Edward Keystone, Mark C Genovese, Paul Emery, Charles Peterfy, Paul Peter Tak, Matt Cravets, Tim Shaw, David Hagerty

Annals of the Rheumatic Diseases Jun 2010, 69 (6) 1158-1161; DOI: 10.1136/ard.2009.119222
Influence of anti-TNF therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: results from the British Society for Rheumatology Biologics Register
W G Dixon, K L Hyrich, K D Watson, M Lunt, BSRBR Control Centre Consortium, D P M Symmons

Annals of the Rheumatic Diseases Jun 2010, 69 (6) 1086-1091; DOI: 10.1136/ard.2009.120626
Investigation of rheumatoid arthritis susceptibility genes identifies association of AFF3 and CD226 variants with response to anti-tumour necrosis factor treatment
Rachael J L Tan, Laura J Gibbons, Catherine Potter, Kimme L Hyrich, Ann W Morgan, Anthony G Wilson, John D Isaacs, BRAGGSS, Anne Barton

Annals of the Rheumatic Diseases Jun 2010, 69 (6) 1029-1035; DOI: 10.1136/ard.2009.118406
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs
Josef S Smolen, Robert Landewé, Ferdinand C Breedveld, Maxime Dougados, Paul Emery, Cecile Gaujoux-Viala, Simone Gorter, Rachel Knevel, Jackie Nam, Monika Schoels, Daniel Aletaha, Maya Buch, Laure Gossec, Tom Huizinga, Johannes W J W Bijlsma, Gerd Burmester, Bernard Combe, Maurizio Cutolo, Cem Gabay, Juan Gomez-Reino, Marios Kouloumas, Tore K Kvien, Emilio Martin-Mola, Iain McInnes, Karel Pavelka, Piet van Riel, Marieke Scholte, David L Scott, Tuulikki Sokka, Guido Valesini, Ronald van Vollenhoven, Kevin L Winthrop, John Wong, Angela Zink, Désirée van der Heijde

Annals of the Rheumatic Diseases Jun 2010, 69 (6) 964-975; DOI: 10.1136/ard.2009.126532
Impact of T-cell costimulation modulation in patients with undifferentiated inflammatory arthritis or very early rheumatoid arthritis: a clinical and imaging study of abatacept (the ADJUST trial)
P Emery, P Durez, M Dougados, C W Legerton, J-C Becker, G Vratsanos, H K Genant, C Peterfy, P Mitra, S Overfield, K Qi, R Westhovens

Annals of the Rheumatic Diseases Mar 2010, 69 (3) 510-516; DOI: 10.1136/ard.2009.119016

Main menu

Open access

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Open access

Pages